Back to News
Market Impact: 0.6

Should You Buy TSM While It's Under $400?

TSMNDAQNFLXNVDA
Artificial IntelligenceTechnology & InnovationCorporate EarningsCorporate Guidance & OutlookAnalyst InsightsCompany FundamentalsTrade Policy & Supply ChainProduct Launches
Should You Buy TSM While It's Under $400?

TSMC reported robust third-quarter results with revenues rising 41% year‑over‑year to $33.1 billion and EPS up 50% to $2.91, driven by accelerating demand for AI-optimized chips and advanced nodes (7nm and below comprised 74% of wafer revenues). Management and industry forecasts point to mid-40% CAGR in AI accelerator demand through 2029, a planned expansion of CoWoS packaging capacity from ~75–80k wafers/month to 120–130k by end‑2026, and volume production of N2P and A16 in 2026; Susquehanna raised its price target to $400, underpinning a bullish outlook for further share gains into 2026.

Analysis

Market structure: TSMC (TSM) is the prime beneficiary of an AI-driven foundry re-rating — advanced nodes (≤7nm) already ~74% of wafer revenue and CoWoS capacity rising from ~75–80k to 120–130k wafers/month by end-2026 implies 50–70% more packaging throughput. Direct winners: hyperscalers, GPU firms (NVDA) and HBM suppliers (MU, Samsung). Losers: legacy-node fabs and any IDMs unable to secure advanced node slots; pricing power for leading-node wafers should stay robust but ASP compression risk exists if capacity outpaces accelerator demand. Risk assessment: Tail risks include China/Taiwan geopolitical escalation causing fabs to halt, export-control shocks restricting equipment (ASML) or customer concentration risk if Nvidia/Apple pull back — each could shave 20–40% off revenue in a downside scenario. Time horizons: expect volatile reactions in days around earnings/Guidance, capacity/capex updates to play out over months, and multi-year revenue tailwinds through 2029 per TSMC's mid-40% AI accelerator CAGR forecast. Hidden dependencies: HBM substrate supply, EUV tool delivery cadence, wafer-supply and power/energy constraints that can bottleneck output even if metrology is available. Trade implications: Primary direct play is long TSM to capture 2026 node ramps and CoWoS scale, complemented by long NVDA and ASML exposure; consider size limits (2–5% portfolio each) given concentration. Use 12–18 month call-spreads on TSM to capture N2P/A16 ramp (targeting payoff if TSM trades +30–50% by 2026); hedge with short exposure to legacy-node peers (INTC or SMIC) as a pair trade to isolate advanced-node upside. Rotate overweight into semiconductor equipment (LRCX, ASML) and underweight commodity memory cyclicals if HBM shortages ease. Contrarian angles: Consensus may underprice execution and geopolitical tail risks and overprice duration — TSM stock is up >40% in 2025 and could suffer a 10–25% pullback on any guide miss. Expansion in CoWoS could create short-term oversupply in 2026 if customers defer builds, pressuring ASPs and margins. Historical parallels: 2017–18 capex cycles show tech cycles can flip to oversupply within 12–24 months; plan risk-defined entries and profit exits accordingly.